C12Y 301/22001
Deoxyribonuclease ii
Official title: Deoxyribonuclease II (3.1.22.1)
C12Y301/22001 (Deoxyribonuclease ii) appears on 13 US grants and 16 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 16
- Assignees
- 13
- Inventors
- 45
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 1 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 2 | 3 |
| 2023 | 1 | 2 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Dnase variants21 Jul 2026US 12,686,857 B2Novozymes A/S
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations20 Jan 2026US 12,529,100 B2Roche Sequencing Solutions, Inc.
- Methods for detecting binding of peptide-MHC monomers to T cells21 Oct 2025US 12,449,419 B110x Genomics, Inc.
- Treatment of aging-associated conditions by DNA degradation26 Sep 2023US 11,766,446 B2The General Hospital Corporation
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations6 Dec 2022US 11,519,026 B2Roche Sequencing Solutions, Inc.
- Novel compositions for disrupting biofilms12 Feb 2026US 2026/0041743 A1The Trustees of Indiana University
- Inhibitors of rna-guided nucleases and uses thereof11 Apr 2024US 2024/0115557 A1The Brigham and Women S Hospital, Inc.
- Dnase Variants28 Dec 2023US 2023/0416706 A1Novozymes A/S
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations9 Mar 2023US 2023/0074210 A1Roche Sequencing Solutions, Inc.
- Novel compositions for disrupting biofilms10 Nov 2022US 2022/0354932 A1The Trustees of Indiana University
Most cited
By later US patents
- Therapeutic for treating Clostridium difficile infection15US 9,205,133 B2London School of Hygiene and Tropical Medicine · 2015
- Deoxyribonuclease IIβ proteins and cDNAs3US 6,358,723 B1Trustees of Dartmouth College · 2002
- Therapeutic for treating clostridium difficile infection1US 10,039,812 B2London School of Hygiene and Tropical Medicine · 2018
- Nonviral minicircle vector carrying SOX gene and construction method therefor1US 11,045,498 B2Dongguk University Industry-Academic Cooperation Foundation · 2021